In Brief: Glaxo Wellcome top exec structure

Glaxo Wellcome top exec structure: Changed to aid the integration of the two companies and includes integration task forces and project teams. Chairing North American operations is Robert Ingram, Glaxo, Inc.'s CEO; Burroughs Wellcome North American Operations Director Phil Tracy to deputy chair; the R&D task force is led by Glaxo's Jim Niedel, MD; the deputy chair is Wellcome's David Barry, MD. Sir Richard Sykes, deputy chairman and CEO of Glaxo, plc, will take direct responsibility for public affairs and corporate strategy functions. Sykes will be the topsider at Glaxo Wellcome. Wellcome plc Chairman John Robb resigned, Wellcome announced March 23. His resignation is effective March 31...